Covered recipient · General Payments record
SABRINA L WILLIAMS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$9,360.57
- Reported across 622 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,039.66 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $218.69 | 7 |
| PFIZER INC. | $167.80 | 6 |
| Inspire Medical Systems, Inc. | $128.79 | 1 |
| Kerecis Limited | $122.70 | 1 |
| DEXCOM, INC. | $119.48 | 5 |
| Lilly USA, LLC | $103.63 | 5 |
| Abbott Laboratories | $100.73 | 5 |
| Exact Sciences Corporation | $58.64 | 3 |
| GlaxoSmithKline, LLC. | $19.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.95 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125336644 | CMS |
| Abbott Laboratories | $18.37 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125336646 | CMS |
| Abbott Laboratories | $18.56 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125336648 | CMS |
| Abbott Laboratories | $24.01 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125336650 | CMS |
| Abbott Laboratories | $21.84 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125336652 | CMS |
| Dexcom, Inc. | $25.20 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153333229 | CMS |
| Dexcom, Inc. | $22.60 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153333231 | CMS |
| Dexcom, Inc. | $24.24 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153333233 | CMS |
| Dexcom, Inc. | $27.24 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153333235 | CMS |
| Dexcom, Inc. | $20.20 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153333237 | CMS |
| Exact Sciences Corporation | $25.61 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114950819 | CMS |
| Exact Sciences Corporation | $16.59 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114950823 | CMS |
| Exact Sciences Corporation | $16.44 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114950826 | CMS |
| GlaxoSmithKline, LLC. | $19.20 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116320688 | CMS |
| Inspire Medical Systems, Inc. | $128.79 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148126273 | CMS |
| Kerecis Limited | $122.70 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120116258 | CMS |
| Lilly USA, LLC | $23.68 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135360546 | CMS |
| Lilly USA, LLC | $19.62 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135380555 | CMS |
| Lilly USA, LLC | $20.83 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135384607 | CMS |
| Lilly USA, LLC | $16.37 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135384605 | CMS |
| Lilly USA, LLC | $23.13 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135397353 | CMS |
| Novo Nordisk Inc | $121.18 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097754125 | CMS |
| Novo Nordisk Inc | $16.00 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097139948 | CMS |
| Novo Nordisk Inc | $20.39 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097752851 | CMS |
| Novo Nordisk Inc | $19.13 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097808021 | CMS |
| Novo Nordisk Inc | $17.41 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097008614 | CMS |
| Novo Nordisk Inc | $17.03 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097254661 | CMS |
| Novo Nordisk Inc | $7.55 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097330406 | CMS |
| PFIZER INC. | $15.08 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130987809 | CMS |
| PFIZER INC. | $12.15 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131917703 | CMS |
| PFIZER INC. | $18.37 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131546558 | CMS |
| PFIZER INC. | $18.07 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131783864 | CMS |
| PFIZER INC. | $86.43 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132023699 | CMS |
| PFIZER INC. | $17.70 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131983231 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.